We then went a step further and demonstrated a protective effect compared to statins, which also have been thought to be anti-inflammatory and protective across numerous organ systems. People taking GLP-1 receptor agonists also had a lower risk of wet AMD compared with people taking statins, insulin and aspirin, and a lower risk of primary open-angle glaucoma compared with people taking metformin, insulin and aspirin
[8] Therefore, it is likely that a number of mechanisms work together to cause individuals to lose NAD+ as they age
The more responsible approach is to address the systems that actually shape brain aging: metabolic health, cardiovascular risk, sleep, movement, body composition, inflammation, sensory health, hormones, nutrition, and long-term function
Kanai Y, Stelzner M, Nussberger S, Khawaja S, Hebert SC, Smith CP, Hediger MA
However, translating these promising findings into clinical success remains a formidable challenge
Our analysis of a series of mutants has revealed that those directly impaired in glutathione biosynthesis exhibited a higher degree of growth reduction than WT